MRSA (n = 142/271) | 52.5% |
MRSA vancomycin R (n = 11/142) | 7.7% |
Enterococcus ampicillin R (n = 64/102) | 62.7% |
Enterococcus vancomycin R (n = 69/102) | 67.6% |
E. coli cefotaxime R (n = 89/221) | 40.2% |
E. coli ESBL + (n = 44/221) | 20.0% |
Acinetobacter baumanii ceftazidimeR (n = 10/10) | 100.0% |
Pseudomonas aeruginosa ceftazidime R (n = 75/110) | 68.2% |